Despite their effectiveness, they come with a range of potential side effects that can impact patient comfort and adherence to treatment
"After two years of chronic shoulder tendinopathy that no PT touched, BPC-157 changed the picture within weeks
Weight loss data is limited compared to GLP-1 agonists
BPC-157 + TB-500 Blend 99.28% pure Dual-peptide research blend of BPC-157 and TB-500 in a 50/50 split, co-lyophilized for focused tissue-repair and regeneration pathway studies
Since the latter are thought to exert their glucose-lowering activity by preventing the degradation and inactivation (with regard to insulinotropic effects) of endogenously released intact, biologically active GLP-1 [9], their pharmacological action should critically depend on availability of the major substrate, GLP-1
The rationale: mechanical stress from training upregulates IGF-1R expression and satellite cell sensitivity